No Data
No Data
CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Down -25.59% in 4 Weeks, Here's Why CytomX Therapeutics (CTMX) Looks Ripe for a Turnaround
Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $3.25
CytomX Therapeutics Price Target Lowered to $3.25 From $3.50 at Piper Sandler
CytomX Therapeutics, Inc. (CTMX) Q3 2024 Earnings Call Transcript Summary
12 Health Care Stocks Moving In Friday's Pre-Market Session
No Data
No Data
Mr Brooks : Thank you. You are amazing. !!!
Trytosaveabit : As you know I’ve been waiting for this 510 clearance! I know most don’t like it! And admittedly the chart and volume are not looking good! Hehehe! But I really like, have like and continue to like MOVE! Hehehe! People don’t realize just how superior this is over the junk you can just buy on Amazon! Hehehe
Jaguar8 OP Trytosaveabit : Yes it took forever for this EvieRing to get cleared even with superior results . Glad they had it
Trytosaveabit Jaguar8 OP : Yup yup! I knew at one point you felt as I do! Not sure where you stand these days? Hehehe.
Jaguar8 OP Trytosaveabit : It was just parked on my FDA watchlist and waited forever
View more comments...